Skip to content

PHARMASENSE

Active Private limited companyfounded 2010active for 16 yearsHeibergstraat 17, 2222 Heist-op-den-BergKBO/BCE: BE 0827.039.024

Timeline

27 events since 2010

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · 28 days late
2025
Highest result from 2010 to 2025 net €157,945 ▲6% The operating result of €240,835 and the net result of €157,945 are both a record.
Annual accounts 2024 filed PDFmicro format · 26 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0827039024
2024
Annual accounts 2023 filed PDFmicro format · 21 days late
2023
Equity above €1m equity €1.1m ▲13.7% With a profit in every financial year since 2010, equity grows to €1.1m.
2 managers resigning, 2 directors reappointed (manager) and (manager) resign · (director) and (director) reappointed6 points ▸
  • General meeting, 22-12-2023
  • resigns as manager
  • resigns as manager
  • reappointed as director, not named in the articles
  • reappointed as director, not named in the articles
  • The registered office is at Heibergstraat 17, 2222 Heist-op-den-Berg (Itegem)
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFmicro format · 31 days late
2022
Annual accounts 2021 filed PDFmicro format · 39 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 31 days late
2020
Annual accounts 2019 filed PDFmicro format · 46 days before the deadline
2019
Annual accounts 2018 filed PDFmicro format · 15 days before the deadline
acts as permanent representativeGeneral meeting of 11-01-20192 points ▸
  • General meeting of 11-01-2019
  • acts as permanent representative

Open the deed in the Belgian Official Gazette

2018
Annual accounts 2017 filed PDFmicro format · 31 days late
2017
Annual accounts 2016 filed PDFmicro format · 12 days before the deadline
2016
Equity above €500,000 equity €501,116 ▲16.8% With a profit in every financial year since 2010, equity grows to €501,116.
Annual accounts 2015 filed PDFabbreviated format · 62 days before the deadline
2015
Annual accounts 2014 filed PDFabbreviated format · 65 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 58 days before the deadline
2013
Equity above €200,000 equity €285,787 ▲50.4% With a profit in every financial year since 2010, equity grows to €285,787.
Annual accounts 2012 filed PDFabbreviated format · 57 days before the deadline
2012
Equity above €150,000 equity €189,992 ▲64% With a profit in every financial year since 2010, equity grows to €189,992.
Annual accounts 2011 filed PDFabbreviated format · 19 days before the deadline
2011
Equity above €100,000 equity €115,833 ▲64.7% With a profit in every financial year since 2010, equity grows to €115,833.
Annual accounts 2010 filed PDFabbreviated format · 34 days before the deadline
2010
First establishment Heibergstraat 17, Heist-op-den-Berg
IncorporationFounding capital of €18,600, 186 shares, €12,400 paid up · Founded by and · (manager) and (manager) appointed · published on 09-07-20105 points ▸
  • Founded by
  • Founded by
  • The founding capital is €18,600, divided into 186 shares
  • appointed as manager
  • appointed as manager
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

PHARMASENSE was incorporated on 25 June 2010 by two private individuals, with a starting capital of €18,600.12 The board currently has 2 members.3 Total assets rose from €1.4m in 2018 to €1.9m in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 09-07-2010
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2018 and 2025

Next steps